Literature DB >> 30768156

DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks.

Mostafa Karimi1,2, Di Wu1, Zhangyang Wang3, Yang Shen1,2.   

Abstract

MOTIVATION: Drug discovery demands rapid quantification of compound-protein interaction (CPI). However, there is a lack of methods that can predict compound-protein affinity from sequences alone with high applicability, accuracy and interpretability.
RESULTS: We present a seamless integration of domain knowledges and learning-based approaches. Under novel representations of structurally annotated protein sequences, a semi-supervised deep learning model that unifies recurrent and convolutional neural networks has been proposed to exploit both unlabeled and labeled data, for jointly encoding molecular representations and predicting affinities. Our representations and models outperform conventional options in achieving relative error in IC50 within 5-fold for test cases and 20-fold for protein classes not included for training. Performances for new protein classes with few labeled data are further improved by transfer learning. Furthermore, separate and joint attention mechanisms are developed and embedded to our model to add to its interpretability, as illustrated in case studies for predicting and explaining selective drug-target interactions. Lastly, alternative representations using protein sequences or compound graphs and a unified RNN/GCNN-CNN model using graph CNN (GCNN) are also explored to reveal algorithmic challenges ahead.
AVAILABILITY AND IMPLEMENTATION: Data and source codes are available at https://github.com/Shen-Lab/DeepAffinity. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Year:  2019        PMID: 30768156      PMCID: PMC6748780          DOI: 10.1093/bioinformatics/btz111

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  32 in total

1.  Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B.

Authors:  L F Iversen; H S Andersen; S Branner; S B Mortensen; G H Peters; K Norris; O H Olsen; C B Jeppesen; B F Lundt; W Ripka; K B Møller; N P Møller
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Calculation of protein-ligand binding affinities.

Authors:  Michael K Gilson; Huan-Xiang Zhou
Journal:  Annu Rev Biophys Biomol Struct       Date:  2007

Review 3.  Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.

Authors:  Andrew R Leach; Brian K Shoichet; Catherine E Peishoff
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

4.  Predicting new molecular targets for known drugs.

Authors:  Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2009-11-01       Impact factor: 49.962

5.  Drug off-target effects predicted using structural analysis in the context of a metabolic network model.

Authors:  Roger L Chang; Li Xie; Lei Xie; Philip E Bourne; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

Review 6.  Rational approaches to improving selectivity in drug design.

Authors:  David J Huggins; Woody Sherman; Bruce Tidor
Journal:  J Med Chem       Date:  2012-01-12       Impact factor: 7.446

7.  BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.

Authors:  Tiqing Liu; Yuhmei Lin; Xin Wen; Robert N Jorissen; Michael K Gilson
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

8.  SCRATCH: a protein structure and structural feature prediction server.

Authors:  J Cheng; A Z Randall; M J Sweredoski; P Baldi
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

9.  PubChem: a public information system for analyzing bioactivities of small molecules.

Authors:  Yanli Wang; Jewen Xiao; Tugba O Suzek; Jian Zhang; Jiyao Wang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2009-06-04       Impact factor: 16.971

10.  STITCH: interaction networks of chemicals and proteins.

Authors:  Michael Kuhn; Christian von Mering; Monica Campillos; Lars Juhl Jensen; Peer Bork
Journal:  Nucleic Acids Res       Date:  2007-12-15       Impact factor: 16.971

View more
  50 in total

Review 1.  Single-Cell Techniques and Deep Learning in Predicting Drug Response.

Authors:  Zhenyu Wu; Patrick J Lawrence; Anjun Ma; Jian Zhu; Dong Xu; Qin Ma
Journal:  Trends Pharmacol Sci       Date:  2020-11-02       Impact factor: 14.819

2.  iLearnPlus: a comprehensive and automated machine-learning platform for nucleic acid and protein sequence analysis, prediction and visualization.

Authors:  Zhen Chen; Pei Zhao; Chen Li; Fuyi Li; Dongxu Xiang; Yong-Zi Chen; Tatsuya Akutsu; Roger J Daly; Geoffrey I Webb; Quanzhi Zhao; Lukasz Kurgan; Jiangning Song
Journal:  Nucleic Acids Res       Date:  2021-06-04       Impact factor: 16.971

3.  Deep Mining from Omics Data.

Authors:  Abeer Alzubaidi; Jonathan Tepper
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 5.  New Insights Into Drug Repurposing for COVID-19 Using Deep Learning.

Authors:  Chun Yen Lee; Yi-Ping Phoebe Chen
Journal:  IEEE Trans Neural Netw Learn Syst       Date:  2021-10-27       Impact factor: 10.451

6.  AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification.

Authors:  Mehdi Yazdani-Jahromi; Niloofar Yousefi; Aida Tayebi; Elayaraja Kolanthai; Craig J Neal; Sudipta Seal; Ozlem Ozmen Garibay
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

7.  Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.

Authors:  Jalil Villalobos-Alva; Luis Ochoa-Toledo; Mario Javier Villalobos-Alva; Atocha Aliseda; Fernando Pérez-Escamirosa; Nelly F Altamirano-Bustamante; Francine Ochoa-Fernández; Ricardo Zamora-Solís; Sebastián Villalobos-Alva; Cristina Revilla-Monsalve; Nicolás Kemper-Valverde; Myriam M Altamirano-Bustamante
Journal:  Front Bioeng Biotechnol       Date:  2022-07-07

8.  Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts.

Authors:  Mostafa Karimi; Di Wu; Zhangyang Wang; Yang Shen
Journal:  J Chem Inf Model       Date:  2020-12-21       Impact factor: 4.956

9.  Crowdsourced mapping of unexplored target space of kinase inhibitors.

Authors:  Anna Cichońska; Balaguru Ravikumar; Robert J Allaway; Fangping Wan; Sungjoon Park; Olexandr Isayev; Shuya Li; Michael Mason; Andrew Lamb; Ziaurrehman Tanoli; Minji Jeon; Sunkyu Kim; Mariya Popova; Stephen Capuzzi; Jianyang Zeng; Kristen Dang; Gregory Koytiger; Jaewoo Kang; Carrow I Wells; Timothy M Willson; Tudor I Oprea; Avner Schlessinger; David H Drewry; Gustavo Stolovitzky; Krister Wennerberg; Justin Guinney; Tero Aittokallio
Journal:  Nat Commun       Date:  2021-06-03       Impact factor: 14.919

10.  Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.

Authors:  Manish Kumar Tripathi; Abhigyan Nath; Tej P Singh; A S Ethayathulla; Punit Kaur
Journal:  Mol Divers       Date:  2021-06-23       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.